On Thursday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Willbros Group Inc. (NYSE:WG), Immune Pharmaceuticals, Inc. (NASDAQ:IMNP), Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Red Hat, Inc. (NYSE:RHT)
Latest NEWS regarding these Stocks are depicted underneath:
Willbros Group Inc. (NYSE:WG)
Willbros Group Inc. (WG), declared that it has closed the transaction for the sale of all outstanding stock of its UtilX partner to Novinium, Inc., Auburn, Washington. Willbros will apply net proceeds from the sale to debt reduction, predictable to be in the range of $35 to $40 million, after customary closing costs and adjustments.
“This attainment will improve industry competition by providing a strong alternative to the capital intensive process of replacing underground utility power cables in order to maintain the world’s aging electrical distribution infrastructure,” said the CEO of Novinium, Glen Bertini. “Failing cable is a top contributor to both rising utility costs and customer power outages, and together UtilX and Novinium can offer the safest, most cost effective solutions for cable rehabilitation, extending the effective cable lifespan by as much as 40 years.”
Willbros is a specialty energy infrastructure contractor serving the oil, gas, refining, petrochemical and power industries. Its offerings comprise engineering, procurement and construction (either individually or as an integrated EPC service offering), maintenance, facilities development and operations services.
Immune Pharmaceuticals, Inc. (NASDAQ:IMNP)
At the very start of this week, Immune Pharmaceuticals, Inc. (IMNP), declared that it has reached a binding memorandum of understanding with Yissum, the Technology Transfer Corporation of the Hebrew University of Jerusalem, to license certain of Yissum’s patents in order to facilitate the development of a topical nanoparticle formulation of Immune’s neuropathic pain drug, AmiKet™.
The technology that Immune will be licensing was invented by Professor Simon Benita, from the Institute for Drug Research, the School of Pharmacy, and Faculty of Medicine at the Hebrew University, a renowned expert in development of drug delivery technology, and a primary inventor of NanomAbs, an antibody nanoparticle conjugate technology to deliver cancer drugs, already licensed by Immune from Yissum.
Immune Pharmaceuticals is presently conducting a search for an appropriate partner for the final development and commercialization of AmiKet, which is ready for Phase III clinical trial in post herpetic neuralgia and has been granted Orphan Drug Designation by the Food and Drug Administration. The Corporation anticipates to select a partner and secure a licensing contract by the second quarter of 2015. The topical nanoparticle formulation of AmiKet will be developed collaboratively by Immune and Yissum upon the execution of a license contract between the parties and will be part of the AmiKet commercialization contract.
Immune Pharmaceuticals, Inc., a clinical stage biopharmaceutical corporation, engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
Inovio Pharmaceuticals, Inc. (INO), declared that Chief Operating Officer, Dr. Niranjan Sardesai, will present at the 3rd Annual Regen Med Investor Day to be held Wednesday, March 25, 2015 at the Metropolitan Club in New York City.
Dr. Sardesai’s presentation will start at 4:05 PM ET. A live-streaming webcast of all panels and corporation presentations, counting Dr. Sardesai’s, will be accessible at: http://www.arminvestorday.com/webcast.
Inovio Pharmaceuticals, Inc., together with its auxiliaries, discovers, develops, and develops synthetic vaccines and immune therapies focusing on cancers and infectious diseases. With an expanding portfolio of immune therapies, the corporation is advancing a growing preclinical and clinical stage product pipeline.
Red Hat, Inc. (NYSE:RHT)
Red Hat, Inc. (RHT), the world’s leading provider of open source solutions, declared that LeShop.ch, the largest online supermarket in Switzerland with 60 percent marketshare of the online grocery market, has selected OpenShift Enterprise, Red Hat’s award-winning on-premise, private Platform-as-a-Service (PaaS), to deploy and manage its new online shopping application. With OpenShift Enterprise, LeShop.ch now has an efficient and scalable platform for developing, running, and operating its online supermarket.
In 2014, LeShop.ch migrated its monolithic online shopping application to a more agile, microservices-based technology platform to raise performance and flexibility, enabling it to better compete in the highly competitive online retail market. To enable this new application architecture, LeShop.ch evaluated several competing PaaS platforms, counting Cloud Foundry, in addition to explored the option to individually create its own homegrown application platform with Docker. LeShop ultimately selected OpenShift Enterprise as the PaaS solution that best met its needs because it offered key functions for development, integration, implementation, and operation and also enabled a hybrid cloud deployment.
OpenShift Enterprise provides LeShop.ch with access to a cloud-based application platform, enhancing its ability to build the applications it needs and have them run in a hybrid cloud architecture, both in their own datacenter and the public cloud. It automates much of the provisioning and administration of the application platform stack in a way that enables LeShop.ch’s IT operations team to more easily meet growing business demands for new application services. OpenShift Enterprise also provides an on-demand, elastic, scalable and fully configured application deployment and runtime environment for application developers, so that they can focus on building these new application services.
LeShop created a new application architecture for its online shopping application compriseing of loosely coupled components, known as microservices. Developers at LeShop.ch broke down the previous monolithic application into dozens of microservices leveraging modular design principles. OpenShift Enterprise was critical in providing a platform for deploying and managing these highly distributed services across a hybrid cloud environment.
Red Hat has also offered LeShop.ch with its award-winning support, counting professional services and training programs, assisting LeShop.ch to build up the expertise to manage both future development projects and the operation of its new online shopping application in-house.
Red Hat, Inc. provides open source software solutions to enterprise customers worldwide. It develops and offers operating system, virtualization, middleware, storage, and cloud technologies.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
